PDS Biotechnology (PDSB) EV/FCF: History & Chart

PDS Biotechnology Corporation(PDSB)

Biotechnology · Princeton, NJ

$0.21-0.01 (-3.21%)

At close: Aug 28, 2026, 4:00 PM ET

About PDS Biotechnology Corporation

PDS Biotechnology Corporation is a clinical-stage biopharmaceutical firm dedicated to advancing innovative, multi-functional immunotherapies to combat cancer. Its primary drug candidate, PDS0101 (HPV16), is currently undergoing Phase II clinical trials, positioned as an initial treatment option for recurrent or metastatic head and neck cancer, human papillomavirus (HPV)-associated malignancies, and cervical cancer. The company's developmental pipeline further includes several preclinical product candidates. These comprise PDS0102, utilizing T-cell receptor gamma alternate reading frame protein (TARP) for prostate and breast cancers; PDS0103 (MUC-1) targeting ovarian, colorectal, lung, and breast cancers; and PDS0104, which incorporates Tyrosinase-related protein 2 for the treatment of melanoma. Beyond oncology, PDS Biotechnology is also engaged in developing treatments for infectious diseases, with candidates such as PDS0201 for tuberculosis, PDS0202 as an investigational influenza vaccine, and PDS0203, a vaccine aimed at preventing COVID-19. The company has established strategic partnerships and licensing agreements with notable entities including the National Institutes of Health, Merck Eprova AG, The U.S. Department of Health and Human Services, and MSD International GmbH. PDS Biotechnology Corporation was founded in 2005 and is headquartered in Florham Park, New Jersey.

Princeton, NJ

21 employees

www.pdsbiotech.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Frank K. Bedu-Addo

View full financials

NAME	MARKET CAP	EV/FCF RATIO	TTM	3Y	5Y
PDS Biotechnology Corporation (PDSB)	$11.79M	N/A	N/A	N/A	N/A
Shoulder Innovations, Inc. (SI)vs ›	$438.82M	N/A	N/A	N/A	N/A
NRC Health (NRC)vs ›	$492.43M	26.23x	34.67x	32.94x	32.15x
Teladoc Health, Inc. (TDOC)vs ›	$1.18B	6.38x	7.04x	8.79x	16.24x
DENTSPLY SIRONA Inc. (XRAY)vs ›	$2.23B	30.09x	44.35x	33.18x	28.97x
TransMedics Group, Inc. (TMDX)vs ›	$3.06B	50.54x	77.12x	93.58x	93.58x
Doximity, Inc. (DOCS)vs ›	$5.00B	16.19x	24.39x	34.84x	49.36x
Merit Medical Systems, Inc. (MMSI)vs ›	$5.40B	28.51x	21.47x	37.13x	41.34x
Hims & Hers Health, Inc. (HIMS)vs ›	$6.43B	84.77x	89.94x	72.78x	73.73x
Chemed Corporation (CHE)vs ›	$6.84B	22.60x	17.87x	25.38x	27.78x

NAME

MARKET CAP

EV/FCF RATIO

TTM

PDS Biotechnology Corporation (PDSB)

$11.79M

N/A

Shoulder Innovations, Inc. (SI)vs ›

$438.82M

N/A

NRC Health (NRC)vs ›

$492.43M

26.23x

34.67x

32.94x

32.15x

Teladoc Health, Inc. (TDOC)vs ›

$1.18B

6.38x

7.04x

8.79x

16.24x

DENTSPLY SIRONA Inc. (XRAY)vs ›

$2.23B

30.09x

44.35x

33.18x

28.97x

TransMedics Group, Inc. (TMDX)vs ›

$3.06B

50.54x

77.12x

93.58x

Doximity, Inc. (DOCS)vs ›

$5.00B

16.19x

24.39x

34.84x

49.36x

Merit Medical Systems, Inc. (MMSI)vs ›

$5.40B

28.51x

21.47x

37.13x

41.34x

Hims & Hers Health, Inc. (HIMS)vs ›

$6.43B

84.77x

89.94x

72.78x

73.73x

Chemed Corporation (CHE)vs ›

$6.84B

22.60x

17.87x

25.38x

27.78x

DATE	EV/FCF RATIO
2018-12-31	1.01x

DATE

EV/FCF RATIO

2018-12-31

1.01x

EV/FCF Ratio: N/A

PDSB EV/FCF Ratio Metrics

PDSB Competitors' EV/FCF Ratio

Cash Flow Valuation Comparison

EV/FCF Ratio Formula & Definition

PDSB EV/FCF Ratio History

Related Metrics